Evidence map›Paper›PMID 40437059›Full record

ArticleScientific reports2025

Improving ACS prediction in T2DM patients by addressing false records in electronic medical records using propensity score.

David Seung U Lee, Jung-Hyun Won, Howard Lee

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

David Seung U LeeDepartment of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, 08826, South Korea.ORCID http://orcid.org/0000-0001-5710-1759
Jung-Hyun WonDepartment of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, 08826, South Korea.ORCID http://orcid.org/0000-0001-7335-8087
Howard LeeDepartment of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, 08826, South Korea. howardlee@snu.ac.kr.ORCID http://orcid.org/0000-0001-6713-5418

Funding

Digital Healthcare Research Grant through the Seokchun Caritas Foundation SCY2205Pthe BK21FOUR Program of the National Research Foundation of Korea (NRF) funded by the Ministry of Education 5120200513755
6 · The paper itself

Abstract

Our study aims to improve the prediction performance of machine learning (ML) models by addressing false records (i.e., false positive, false negative, or missingness) in binary categorical variables in electronic medical records (EMRs) using propensity score (PS). This study used the EMRs of patients with type 2 diabetes mellitus (T2DM) treated with basal insulin at a tertiary university hospital in South Korea. We expanded the definition of PS into the probability of having a record for a binary variable given covariates. We calculated PS for the binary categorical variables in their EMRs and developed PS datasets. By utilizing various ML algorithms, we developed and validated ACS prediction models on 80% and 20% of the dataset, respectively. We evaluated model performance using accuracy, recall, precision, F1 score, and AUROC. Additionally, the Shapley Additive Explanation (SHAP) method was used to identify important clinical predictors of ACS. The study included 9,338 patients (with an average age of 60.2 years and 56.6% of whom were male) over 10,184 treatment periods. The most prevalent comorbidities were hypertension (31.5%) and dyslipidemia (28.9%). Notably, 6.9% experienced ACS during their insulin treatment. The ML models trained on PS datasets generally outperformed the models trained on raw datasets. The results of SHAP analysis showed that older age, higher baseline weight, higher baseline glucose, history of antithrombotic therapy, history of chest pain, and indicators of T2DM progression (e.g., senile cataract) were important ACS risk factors. We have developed an ACS prediction model with an improved performance and higher reliance on clinical predictors that are in alignment with current medical understanding.

Indexed as

Diabetes Mellitus, Type 2Electronic Health RecordsAgedAlgorithmsComorbidityFemaleHumansMachine LearningMaleMiddle AgedPropensity ScoreRepublic of KoreaAcute coronary syndromeInsulinPropensity scoreRisk predictionType 2 diabetes mellitus

Identifiers

PMID40437059
PMCPMC12120027

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.